Ioversol

CHEMBL1200614 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
807.1 g/mol
LogP
-3.0
Phase
4

This non-ionic, low-osmolality iodinated contrast agent is used for coronary angiography, CT scans, urography, and other diagnostic imaging. Its favorable safety profile makes it suitable for a wide range of patients including those with mild to moderate renal impairment. Standard precautions for iodinated contrast including allergy screening and post-procedure hydration apply.

Khối lượng phân tử

807,1000 g/mol

LogP

-3,00

TPSA

200,00 Ų

Lipinski RO5

Không đạt

Lĩnh vực điều trị

Cơ chế tác dụng

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(NCC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(N(CCO)C(=O)CO)c1I

InChI

InChI=1S/C18H24I3N3O9/c19-13-11(17(32)22-3-8(29)5-26)14(20)16(24(1-2-25)10(31)7-28)15(21)12(13)18(33)23-4-9(30)6-27/h8-9,25-30H,1-7H2,(H,22,32)(H,23,33)

Molecular Formula

C18H24I3N3O9

HBD / HBA

8 / 9

Liên kết có thể quay

12

Nguyên tử nặng

33

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This non-ionic, low-osmolality iodinated contrast agent is used for coronary angiography, CT scans, urography, and other diagnostic imaging. Its favorable safety profile makes it suitable for a wide range of patients including those with mild to moderate renal impairment. Standard precautions for iodinated contrast including allergy screening and post-procedure hydration apply.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Ioversol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200614. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3741. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.